Generics 14

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Iohexol manufacturers

14 products found

Filters

14 products found

iohexol

Vials, injection 300 mg/ml , 350 mg/ml - 50 ml, 100 ml, 125 ml, 150 ml, 200 ml, 500 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Denmark , Pakistan , Serbia , Ukraine , Vietnam
Manufacturer #16341
The business is vertically integrated, with over 20 years of experience in chemical synthesis and manufacturing of generic Active Pharmaceutical Ingredients and Drug Products. Oversight of the supply chain for high-quality generic contrast agents for radiologic diagnostics such as X-rays, CT, and MRI.

Manufacturer usually replies in 8 days

iohexol

Solution for injection 350 mg/ml, 300 mg/ml, 240 mg/ml - 20 ml, 50 ml, 100 ml, 200 ml, 500 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Belarus , Iraq , Kazakhstan , Russia , Ukraine , Uzbekistan , Vietnam
Available for
Licensing with supply
Comments
Dossier availability date: Q4 2023
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

iohexol

Solution for injection 300 mg/ml, 350 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Unavailable markets
Albania , Vietnam
Manufacturer #2760

Manufacturer usually replies in 5 days

iohexol

Vials, injection 240 mg, 300 mg, 350 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP, PICS
Available for
Distribution only
Manufacturer #18087
It is one of the leading specialty pharmaceutical companies. The company specializes in ophthalmology, an image contrast agent (MRI and CT), and gastrointestinal products. It is an FDA and EU-GMP-approved manufacturer exporting ophthalmic products to U.S., EU, and Asia.

Manufacturer usually replies in 10 days

iohexol

Vials, injection 300 mg/ml, 350 mg/ml - 50 ml, 100 ml, 200 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS, EU GMP
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

iohexol

Concentrate for solution for injection 300 mg/ml, 350 mg/ml - 50 ml, 100 ml, 200 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, ANVISA
Unavailable markets
Pakistan
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

iohexol

Solution for infusion 300 mg, 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

iohexol

Injection 300 mg, 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20700

Manufacturer usually replies in 5 days

iohexol

Vials, injection 647 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #17938
The company is focused to produce the best products with the experience and practical know-how and willingness to become a company that always keeps on trying to do its best. They produce excellent medicine suitable for GMP requirements through strict quality management in each step from the warehousing of raw materials to the manufacturing process, packing, and shipment. Productivity maximization, as well as quality assurance, is enhanced with recently introduced various manufacturing facilities.

Manufacturer usually replies in 2 days

iohexol

Solution for injection 15 g, 17.5 g, 22.5 g, 30 g, 35 g - 50 ml , 75 ml , 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #12677

Manufacturer usually replies in 4 days

iohexol

Solution for injection 300 mg/ml, 350 mg/ml - 50 ml, 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Available for Balkans only
Manufacturer #17331

Manufacturer usually replies in 8 days

iohexol

Solution for infusion 300 mg, 350 mg - 50 ml, 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
WHO
Unavailable markets
Philippines
Manufacturer #559

Manufacturer usually replies in 8 days

iohexol

Bags for injection/infusion 518 mg/ml, 647 mg/ml, 755 mg/ml - 10 ml, 20 ml, 50 ml, 85 ml, 100 ml, 125 ml, 130 ml, 150 ml,200 ml, 500 ml, 1 l

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #17971
It was one of the leading manufacturers of infusion solutions. The company manufactured the first infusion as the basis of national health, opening a new horizon for medical companies and growing as a representative infusion manufacturer. They have procured over 200 types of finished medicines for treatment, and they are leading markets for therapeutic drugs and keeping patients healthy in diverse medical fields.

Manufacturer usually replies in 9 days

iohexol

Injection 17.5 g, 30 g - 50 ml, 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

Iohexol Manufacturers

Iohexol contains iodine and belongs to a class of drugs known as non-ionic iodinated contrast media or dyes which is an effective non-ionic, water-soluble contrast agent. Iohexol is used in myelography, arthrography, nephron angiography, arteriography, and other radiographic procedures. This medication is advised as a prescription product only. Iohexol is marketed by manufacturers under the Brand name of Omnipaque, Oraltag, Nycodenz. This drug is available in the dosage form of an injection solution, solution, liquid. Iohexol solution is administered via a wide variety of routes like intravenously, intravascularly, intra-articularly, oral, rectal, intrathecal, and subarachnoid. Intrathecal half-life is 3.4 hours and Intravascular half-life is approximately 2 hours with normal renal function. Iohexol is available in a dosage strength of 10 mL, 20 mL, 50 mL, 100 mL supplied in a glass vial or glass bottle. The Intrathecal administration of Iohexol in adults is 180 mg or 240 mg or 300 mg of iodine per mL for lumbar, thoracic, cervical, and total columnar myelography. In pediatrics, Iohexol 180 mg of iodine per mL is administered intravascularly for lumbar, thoracic, cervical, and total columnar myelography. The intravascular administration of iohexol in adults is 140 mg of iodine per mL is given for intra-arterial digital subtraction angiography of the head, neck, abdominal, renal, and peripheral vessels. Iohexol 240 is administered intravascularly for CT head imaging and for peripheral venography. In pediatrics, iohexol 240 is administered for CT head and body imaging, and Iohexol 300 is used for angiocardiography, excretory urography, and CT head and body imaging. For oral and rectal administration, iohexol 350 is given for oral radiographic examination of the gastrointestinal tract while iohexol 180, 240, 300 is administered orally and rectally for radiographic examination of the gastrointestinal tract. Iohexol is recommended to store at a controlled room temperature of 20° C - 25° C (68° F - 77° F). Excursions permitted to 15° C to 30° C (59° F to 86° F).

Wholesale Price of Iohexol

The wholesale price of Iohexol 350 injectable solution (350 mg/mL) is around $ 130.08 for a supply of 125 milliliters with per unit cost at $ 1.04, and the cost for 500 milliliters is priced between $ 536.50 - $ 588.98 with unit price available for $ 1.07 - $ 1.18 depending up on the pharmacy one visit.

Iohexol - Mechanism of Action

The iodine atoms in iohexol provide attenuation of X-rays in direct proportion to the concentration of iohexol. Since concentration changes over time, iohexol provides time-dependent image contrast which may assist in visualizing body structures. Iohexol is absorbed from cerebrospinal fluid (CSF) into the bloodstream and is eliminated by renal excretion. No significant metabolism, deiodination, or biotransformation occurs. After intrathecal administration into the subarachnoid space, diffusion of iohexol in the CSF allows the visualization of the subarachnoid spaces of the head and spinal canal. After intravascular administration, iohexol makes opaque vessels in its path of flow, allowing visualization of the internal structures until significant hemodilution occurs.

Finding Iohexol Manufacturers and Suppliers

To find a trustworthy partner in our business is one of the biggest challenges and to defeat that and to make one’s work/life easy in finding the reliable manufacturer and supplier of Iohexol one can visit the Pipelinepharma website which helps the buyer in finding the dependable manufacturers and suppliers of Iohexol. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects the proprietor with the consumers for business development. The buyer can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.